4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001202098-26-000002
Options or other derivatives
- Director acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| PAPADOPOULOS STELIOS Director | 2026-02-26 | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | D | ||
Loading xslF345X05/form4-03022026_040315.xml…